The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Tuesday's announcement is part of the Trump administration's efforts to reduce prescription drug costs for Americans, with ...

CMS will negotiate the prices for Trulicity, Biktarvy and 13 other high-cost medications commonly covered by Medicaid Parts B and D, according to a Jan. 27 news release from the agency.  The Medicare ...

The Trump administration’s plan to lower US drug costs through two new pricing models is prompting legal concerns from the ...

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...